Ascendis Pharma
ASND
ASND
218 hedge funds and large institutions have $9.31B invested in Ascendis Pharma in 2024 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 79 increasing their positions, 68 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 17 → 17 (0)
1.23% less ownership
Funds ownership: 105.16% → 103.93% (-1.2%)
33% less call options, than puts
Call options by funds: $39.3M | Put options by funds: $58.8M
Holders
218
Holding in Top 10
17
Calls
$39.3M
Puts
$58.8M
Top Buyers
| 1 | +$259M | |
| 2 | +$118M | |
| 3 | +$105M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$74M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$50.3M |
Top Sellers
| 1 | -$202M | |
| 2 | -$100M | |
| 3 | -$90.6M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$80.3M |
| 5 |
VPC
Vestal Point Capital
New York
|
-$74.7M |